<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Cardiol</journal-id><journal-id journal-id-type="iso-abbrev">Clin Cardiol</journal-id><journal-id journal-id-type="pmc-domain-id">3639</journal-id><journal-id journal-id-type="pmc-domain">clincardiol</journal-id><journal-id journal-id-type="publisher-id">CLC</journal-id><journal-title-group><journal-title>Clinical Cardiology</journal-title></journal-title-group><issn pub-type="ppub">0160-9289</issn><issn pub-type="epub">1932-8737</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6489822</article-id><article-id pub-id-type="pmcid-ver">PMC6489822.1</article-id><article-id pub-id-type="pmcaid">6489822</article-id><article-id pub-id-type="pmcaiid">6489822</article-id><article-id pub-id-type="pmid">29604091</article-id><article-id pub-id-type="doi">10.1002/clc.22955</article-id><article-id pub-id-type="publisher-id">CLC22955</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Clinical Investigations</subject></subj-group><subj-group subj-group-type="heading"><subject>Clinical Investigations</subject></subj-group></article-categories><title-group><article-title>Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy</article-title><alt-title alt-title-type="left-running-head">Figliuzzi et al</alt-title></title-group><contrib-group><contrib id="clc22955-cr-0001" contrib-type="author"><name name-style="western"><surname>Figliuzzi</surname><given-names initials="I">Ilaria</given-names></name><xref ref-type="aff" rid="clc22955-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="clc22955-cr-0002" contrib-type="author"><name name-style="western"><surname>Presta</surname><given-names initials="V">Vivianne</given-names></name><xref ref-type="aff" rid="clc22955-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="clc22955-cr-0003" contrib-type="author"><name name-style="western"><surname>Citoni</surname><given-names initials="B">Barbara</given-names></name><xref ref-type="aff" rid="clc22955-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="clc22955-cr-0004" contrib-type="author"><name name-style="western"><surname>Miceli</surname><given-names initials="F">Francesca</given-names></name><xref ref-type="aff" rid="clc22955-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="clc22955-cr-0005" contrib-type="author"><name name-style="western"><surname>Simonelli</surname><given-names initials="F">Francesca</given-names></name><xref ref-type="aff" rid="clc22955-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="clc22955-cr-0006" contrib-type="author"><name name-style="western"><surname>Battistoni</surname><given-names initials="A">Allegra</given-names></name><xref ref-type="aff" rid="clc22955-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="clc22955-cr-0007" contrib-type="author"><name name-style="western"><surname>Coluccia</surname><given-names initials="R">Roberta</given-names></name><xref ref-type="aff" rid="clc22955-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="clc22955-cr-0008" contrib-type="author"><name name-style="western"><surname>Ferrucci</surname><given-names initials="A">Andrea</given-names></name><xref ref-type="aff" rid="clc22955-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="clc22955-cr-0009" contrib-type="author"><name name-style="western"><surname>Volpe</surname><given-names initials="M">Massimo</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-2395-7572</contrib-id><xref ref-type="aff" rid="clc22955-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="clc22955-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="clc22955-cr-0010" contrib-type="author" corresp="yes"><name name-style="western"><surname>Tocci</surname><given-names initials="G">Giuliano</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0635-4921</contrib-id><address><email>giuliano.tocci@uniroma1.it</email></address><xref ref-type="aff" rid="clc22955-aff-0001">
<sup>1</sup>
</xref><xref ref-type="aff" rid="clc22955-aff-0002">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="clc22955-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology</named-content>
<institution>University of Rome Sapienza, Sant'Andrea Hospital</institution>
<named-content content-type="city">Rome</named-content>
<country country="IT">Italy</country>
</aff><aff id="clc22955-aff-0002" content-type="private-address">
<label><sup>2</sup></label>
<institution>IRCCS Neuromed</institution>
<named-content content-type="city">Pozzilli</named-content>
<country country="IT">Italy</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break/>
Giuliano Tocci, MD, PhD, Division of Cardiology, Department of Clinical and Molecular Medicine, Faculty of Medicine and Psychology, University of Rome Sapienza, Sant'Andrea Hospital, Rome, Italy<break/>
Email: <email>giuliano.tocci@uniroma1.it</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>6</month><year>2018</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2018</year></pub-date><volume>41</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">333590</issue-id><issue-id pub-id-type="doi">10.1002/clc.2018.41.issue-6</issue-id><fpage>788</fpage><lpage>796</lpage><history><date date-type="received"><day>03</day><month>2</month><year>2018</year></date><date date-type="rev-recd"><day>10</day><month>3</month><year>2018</year></date><date date-type="accepted"><day>27</day><month>3</month><year>2018</year></date></history><pub-history><event event-type="pmc-release"><date><day>05</day><month>06</month><year>2018</year></date></event><event event-type="pmc-live"><date><day>28</day><month>08</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-08-29 00:18:15.747"><day>29</day><month>08</month><year>2019</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2018 Wiley Periodicals, Inc.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="CLC-41-788.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:CLC-41-788.pdf"/><abstract><sec id="clc22955-sec-0001"><title>Background</title><p>Pharmacological therapy in patients at high cardiovascular (CV) risk should be tailored to achieve recommended therapeutic targets.</p></sec><sec id="clc22955-sec-0101"><title>Hypothesis</title><p>To evaluate individual global CV risk profile and to estimate the control rates of multiple therapeutic targets for in adult outpatients followed in real practice in Italy.</p></sec><sec id="clc22955-sec-0002"><title>Methods</title><p>Data extracted from a cross&#8208;sectional, national medical database of adult outpatients in real practice in Italy were analyzed for global CV risk assessment and rates of control of major CV risk factors, including hypertension, dyslipidemia, diabetes, and obesity. CV risk characterization was based on the European SCORE equation and the study population stratified into 3 groups: low risk (&lt;2%), intermediate risk (&#8805;2%&#8211;&lt;5%), and high to very high risk (&#8805;5%).</p></sec><sec id="clc22955-sec-0003"><title>Results</title><p>We analyzed data from 7158 adult outpatients (mean age, 57.7&#8201;&#177;5.3&#8201;years; BMI, 28.3&#8201;&#177;5.0&#8201;kg/m<sup>2</sup>, BP, 136.0&#8201;&#177;14.3/82.2&#8201;&#177;8.3&#8201;mm Hg; total cholesterol, 212.7&#8201;&#177;40.7&#8201;mg/dL), among whom 2029 (45.2%) had low, 1730 (24.2%) intermediate, and 731 (16.3%) high to very high risk. Increased SCORE risk was an independent predictor of poor achievement of diastolic BP &lt;90&#8201;mm Hg (OR: 0.852, 95% CI: 0.822&#8211;0.882), LDL&#8208;C&#8201;&lt;&#8201;130&#8201;mg/dL (OR: 0.892, 95% CI: 0.861&#8211;0.924), HDL&#8208;C&#8201;&gt;&#8201;40 (males)/&gt;50 (females) mg/dL (OR: 0.926, 95% CI: 0.895&#8211;0.958), triglycerides &lt;160&#8201;mg/dL (OR: 0.925, 95% CI: 0.895&#8211;0.957), and BMI &lt;25&#8201;kg/m<sup>2</sup> (OR: 0.888, 95% CI: 0.851&#8211;0.926), even after correction for diabetes, renal function, pharmacological therapy, and referring physicians (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.001).</p></sec><sec id="clc22955-sec-0004"><title>Conclusions</title><p>Despite low prevalence and optimal medical therapy, individuals with high to very high SCORE risk did not achieve recommended therapeutic targets in a real&#8208;world practice.</p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="clc22955-kwd-0001">Diabetes</kwd><kwd id="clc22955-kwd-0002">Dyslipidemia</kwd><kwd id="clc22955-kwd-0003">European Risk SCORE</kwd><kwd id="clc22955-kwd-0004">Global Cardiovascular Risk</kwd><kwd id="clc22955-kwd-0005">Hypertension</kwd><kwd id="clc22955-kwd-0006">Obesity</kwd><kwd id="clc22955-kwd-0007">Smoking</kwd><kwd id="clc22955-kwd-0008">Therapeutic Targets</kwd></kwd-group><counts><fig-count count="1"/><table-count count="3"/><page-count count="9"/><word-count count="5848"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>clc22955</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>June 2018</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.2.1 mode:remove_FC converted:30.04.2019</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="clc22955-cit-9001"><string-name name-style="western"><surname>Figliuzzi</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Presta</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Citoni</surname><given-names>B</given-names></string-name>, et al. <article-title>Achievement of multiple therapeutic targets for cardiovascular disease prevention: Retrospective analysis of real practice in Italy</article-title>. <source xml:lang="en">Clin Cardiol</source>. <year>2018</year>;<volume>41</volume>:<fpage>788</fpage>&#8211;<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1002/clc.22955</pub-id><pub-id pub-id-type="pmid">29604091</pub-id><pub-id pub-id-type="pmcid">PMC6489822</pub-id></mixed-citation>
</p></notes></front></article></pmc-articleset>